<table id="i2701ab16-2652-4ec2-8de5-ab42159dd391" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="169"></col>
<col width="150"></col>
<col width="159"></col>
<col width="159"></col>
<thead>
<tr>
<td>
<br/>
</td>
<td>Accumulation <br/>Factor <br/>AUC (0-24 hr, <br/>day 
15)/AUC <br/>(0-24 hr, day 1)</td>
<td>Mean Peak <br/>Serum <br/>Concentration</td>
<td>Mean (SD) <br/>Post-Steady <br/>State 
Half-Life</td>
</tr>
</thead>
<tbody>
<tr>
<td>7- α-(thiomethyl)<br/>spironolactone (TMS)</td>
<td>
<br/>1.25</td>
<td>391 ng/mL<br/>at 3.2 hr</td>
<td>13.8 hr (6.4)<br/>(terminal)<br/>
</td>
</tr>
<tr>
<td>6- β-hydroxy-7- α- (thiomethyl)-<br/>spirolactone 
(HTMS)</td>
<td>
<br/>1.50</td>
<td>
<br/>125 ng/mLat 5.1 hr</td>
<td>
<br/>15.0 hr (4.0)<br/>(terminal)<br/>
</td>
</tr>
<tr>
<td>
<br/>Canrenone (C)</td>
<td>
<br/>1.41</td>
<td>181 ng/mL <br/>at 4.3 hr</td>
<td>16.5 hr (6.3) (terminal)<br/>
</td>
</tr>
<tr>
<td>
<br/>
<br/>Spironolactone</td>
<td>
<br/>
<br/>1.30</td>
<td>
<br/>80 ng/mL<br/>at 2.6 hr</td>
<td>Approximately<br/>1.4 hr (0.5)<br/>(β 
half-life)</td>
</tr>
</tbody>
</table>